Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-41968 SOLVENTUM CORPORATION (Exact name of registrant as specified in its charter) Delaware 92-2008 ...

Exhibit 99.1 Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance • Separation activities and business continuity on track • Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3% • GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS of $1.56 • Generated $355 million in cash from operations; free cash flow of $297 million • Raises full-year 2024 organic sales growth and adjusted EPS guidance 1 1 ST. PAUL, Minn., August 8, 2024 /PRNewswire/ – Solventum ...

Table of Contents Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $.01 Per Share SOLV New York Stock Exchange Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☐ Emerging growth company ☐ Common Stock, $0.01 par value per share 172,709,505 shares 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT ...